Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth

Jiang-Sha Zhao1,2, Shuo Shi3, Hai-Yan Qu4

  • 1Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. zhaojsh@zju.edu.cn.

Nature Metabolism
|February 11, 2022
PubMed

Insights

Glutamine synthetase (GS) drives cancer cell proliferation by regulating mitosis, independent of its metabolic role. Depleting GS halts cancer growth and enhances chemotherapy, revealing a novel therapeutic target.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Metabolic enzymes are reprogrammed in tumors.
  • Key metabolic enzymes have not been known to directly regulate cell mitosis.
  • Glutamine synthetase (GS) is an essential metabolic enzyme.

Purpose of the Study:

  • To investigate the non-metabolic functions of glutamine synthetase (GS).
  • To determine if GS directly regulates cell mitosis and cancer proliferation.
  • To explore GS as a potential therapeutic target in non-small cell lung cancer.

Main Methods:

  • Depletion of GS in cancer cell lines, organoids, and xenografts.
  • Assessing mitotic progression and cell cycle regulation.
  • Investigating the interaction between GS, NUP88, and CDC20.
  • Evaluating tumor growth and chemotherapy efficacy in mouse models.

Main Results:

  • GS depletion, not enzymatic inhibition, caused mitotic arrest and multinucleation.
  • GS directly interacts with NUP88, preventing its binding to CDC20.
  • This interaction is crucial for the metaphase-to-anaphase transition.
  • GS is overexpressed in non-small cell lung cancer, and its depletion reduced tumor growth and improved chemotherapy response.

Conclusions:

  • Glutamine synthetase (GS) possesses a moonlighting function in governing cell mitosis.
  • GS promotes cancer cell proliferation and tumor development beyond its metabolic role.
  • Targeting GS offers a novel strategy for cancer therapy, particularly in combination with microtubule-targeting agents.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
4.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K